myelofibrosis

n.

骨髓纤维变性；

Myelofibrosis with Myeloid Metaplasia
Ruxolitinib for myelofibrosis
JAK Inhibitor in CALR-Mutant Myelofibrosis
JAK Inhibitor in CALR-Mutant Myelofibrosis
A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis
Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis
MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia
Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis
JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis
New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Resear...